| Inhibition of acetyl-CoA carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma JSV Lally, S Ghoshal, DK DePeralta, O Moaven, L Wei, R Masia, ... Cell metabolism 29 (1), 174-182. e5, 2019 | 280 | 2019 |
| Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition S Nakagawa, L Wei, WM Song, T Higashi, S Ghoshal, RS Kim, CB Bian, ... Cancer cell 30 (6), 879-890, 2016 | 188 | 2016 |
| Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation J Bates, A Vijayakumar, S Ghoshal, B Marchand, S Yi, D Kornyeyev, ... Journal of hepatology 73 (4), 896-905, 2020 | 142 | 2020 |
| Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy DJ Erstad, M Sojoodi, MS Taylor, S Ghoshal, AA Razavi, ... Disease models & mechanisms 11 (7), dmm034793, 2018 | 107 | 2018 |
| Metformin prevents hepatocellular carcinoma development by suppressing hepatic progenitor cell activation in a rat model of cirrhosis DK DePeralta, L Wei, S Ghoshal, B Schmidt, GY Lauwers, M Lanuti, ... Cancer 122 (8), 1216-1227, 2016 | 84 | 2016 |
| Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice S Alsamman, SA Christenson, A Yu, NME Ayad, MS Mooring, JM Segal, ... Science translational medicine 12 (557), eaay8798, 2020 | 77 | 2020 |
| Loss of MIG6 accelerates initiation and progression of mutant epidermal growth factor receptor–driven lung adenocarcinoma TK Maity, A Venugopalan, I Linnoila, CM Cultraro, A Giannakou, R Nemati, ... Cancer discovery 5 (5), 534-549, 2015 | 65 | 2015 |
| Progressive decrease of phosphocreatine, creatine and creatine kinase in skeletal muscle upon transformation to sarcoma S Patra, S Bera, S SinhaRoy, S Ghoshal, S Ray, A Basu, U Schlattner, ... The FEBS journal 275 (12), 3236-3247, 2008 | 57 | 2008 |
| Mulberry non-engineered silk gland protein vis-a-vis silk cocoon protein engineered by silkworms as biomaterial matrices J Kundu, M Dewan, S Ghoshal, SC Kundu Journal of Materials Science: Materials in Medicine 19, 2679-2689, 2008 | 54 | 2008 |
| Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP‐305, a novel farnesoid X receptor agonist DJ Erstad, CT Farrar, S Ghoshal, R Masia, DS Ferreira, YCI Chen, ... Hepatology communications 2 (7), 821-835, 2018 | 49 | 2018 |
| Fibrotic response to neoadjuvant therapy predicts survival in pancreatic cancer and is measurable with collagen-targeted molecular MRI DJ Erstad, M Sojoodi, MS Taylor, VC Jordan, CT Farrar, AL Axtell, ... Clinical Cancer Research 26 (18), 5007-5018, 2020 | 37 | 2020 |
| STAT3 is a key transcriptional regulator of cancer stem cell marker CD133 in HCC S Ghoshal, BC Fuchs, KK Tanabe Hepatobiliary surgery and nutrition 5 (3), 201, 2016 | 37 | 2016 |
| Pioglitazone reduces hepatocellular carcinoma development in two rodent models of cirrhosis S Li, S Ghoshal, M Sojoodi, G Arora, R Masia, DJ Erstad, M Lanuti, ... Journal of Gastrointestinal Surgery 23 (1), 101-111, 2019 | 35 | 2019 |
| The farnesoid X receptor agonist EDP‐305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction S Li, S Ghoshal, M Sojoodi, G Arora, R Masia, DJ Erstad, DS Ferriera, Y Li, ... The FASEB Journal 33 (6), 7103, 2019 | 31 | 2019 |
| RPTOR, a novel target of miR-155, elicits a fibrotic phenotype of cystic fibrosis lung epithelium by upregulating CTGF M Tsuchiya, S Kalurupalle, P Kumar, S Ghoshal, Y Zhang, E Lehrmann, ... RNA biology 13 (9), 837-847, 2016 | 27 | 2016 |
| Differential inhibition/inactivation of mitochondrial complex I implicates its alteration in malignant cells A Ghosh, S Bera, S Ghosal, S Ray, A Basu, M Ray Biochemistry (Moscow) 76, 1051-1060, 2011 | 27 | 2011 |
| Tricyclic antidepressants promote ceramide accumulation to regulate collagen production in human hepatic stellate cells JY Chen, B Newcomb, C Zhou, JV Pondick, S Ghoshal, SR York, ... Scientific Reports 7 (1), 44867, 2017 | 23 | 2017 |
| Precision Liver Cancer Prevention Consortium Molecular liver cancer prevention in cirrhosis by Organ transcriptome analysis and lysophosphatidic acid pathway inhibition S Nakagawa, L Wei, WM Song, T Higashi, S Ghoshal, RS Kim, CB Bian, ... Cancer Cell 30 (6), 879-890, 2016 | 14 | 2016 |
| Hepatocellular carcinoma chemoprevention by targeting the angiotensin-converting enzyme and EGFR transactivation E Crouchet, S Li, M Sojoodi, S Bandiera, N Fujiwara, H El Saghire, S Zhu, ... JCI insight 7 (13), 2022 | 9 | 2022 |
| A novel farnesoid X receptor agonist: EDP-305, reduces fibrosis progression in animal models of fibrosis DJ Erstad, CT Farrar, R Masia, DDS Ferreira, L Wei, JK Choi, S Ghoshal, ... Journal of Hepatology 1 (66), S165, 2017 | 5 | 2017 |
